> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# FDA Moves to Daily Drug Adverse Event Data
- URL: https://www.fdaweb.com/fda-moves-to-daily-drug-adverse-event-data/
- Published: 2025-08-22T12:00:00.000Z
- Updated: 2026-09-14T15:19:48.000Z
- Author: David McFarland
- Tags: Drugs, #legacy-id-D5159741

FDA says it will now publish drug safety data on a daily basis, a shift the agency says will give the public faster access to information about adverse events tied to prescription drugs and biologics. The move marks a major change to FDA’s Adverse Event Reporting System (FAERS), which has historically released data in quarterly updates. FAERS collects reports of serious side effects, medication errors, and product quality issues from health professionals, consumers, and manufacturers.

“Adverse event reporting should be fast, seamless and transparent,” FDA commissioner **Marty Makary** is quoted in a [release](https://www.fda.gov/news-events/press-announcements/fda-begins-real-time-reporting-adverse-event-data?ref=fdaweb.com) as saying. “People who navigate the government’s clunky adverse event reporting Web sites should not have to wait months for that information to become public. We’re closing that waiting period and will continue to streamline the process from start to finish.”

The agency framed the change as part of a broader effort to modernize its data infrastructure and increase the frequency of reporting across multiple safety monitoring platforms. Officials said more frequent updates could help regulators and clinicians spot safety signals earlier, potentially averting harm.

The latest information is available through the [FAERS Public Dashboard](https://www.fda.gov/drugs/fdas-adverse-event-reporting-system-faers/fda-adverse-event-reporting-system-faers-public-dashboard?ref=fdaweb.com).